These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 31033015)
1. LncRNA AWPPH and miRNA-21 regulates cancer cell proliferation and chemosensitivity in triple-negative breast cancer by interacting with each other. Liu AN; Qu HJ; Gong WJ; Xiang JY; Yang MM; Zhang W J Cell Biochem; 2019 Sep; 120(9):14860-14866. PubMed ID: 31033015 [TBL] [Abstract][Full Text] [Related]
2. LncRNA NEF is downregulated in triple negative breast cancer and correlated with poor prognosis. Song X; Liu Z; Yu Z Acta Biochim Biophys Sin (Shanghai); 2019 Apr; 51(4):386-392. PubMed ID: 30839051 [TBL] [Abstract][Full Text] [Related]
3. LncRNA AWPPH promotes the growth of triple-negative breast cancer by up-regulating frizzled homolog 7 (FZD7). Wang K; Li X; Song C; Li M Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30333256 [No Abstract] [Full Text] [Related]
4. LncRNA PTCSC3 inhibits triple-negative breast cancer cell proliferation by downregulating lncRNA H19. Wang N; Hou M; Zhan Y; Sheng X J Cell Biochem; 2019 Sep; 120(9):15083-15088. PubMed ID: 31026090 [TBL] [Abstract][Full Text] [Related]
5. lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150. Luo H; Xu C; Le W; Ge B; Wang T J Cell Biochem; 2019 Aug; 120(8):13487-13493. PubMed ID: 30916832 [TBL] [Abstract][Full Text] [Related]
6. LncRNA AWPPH accelerates the progression of non-small cell lung cancer by sponging miRNA-204 to upregulate CDK6. Wu D; Qin BY; Qi XG; Hong LL; Zhong HB; Huang JY Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4281-4287. PubMed ID: 32373964 [TBL] [Abstract][Full Text] [Related]
7. LncRNA CARMN overexpression promotes prognosis and chemosensitivity of triple negative breast cancer via acting as miR143-3p host gene and inhibiting DNA replication. Sheng X; Dai H; Du Y; Peng J; Sha R; Yang F; Zhou L; Lin Y; Xu S; Wu Y; Yin W; Lu J J Exp Clin Cancer Res; 2021 Jun; 40(1):205. PubMed ID: 34162418 [TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p. Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177 [TBL] [Abstract][Full Text] [Related]
9. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling. Han C; Li X; Fan Q; Liu G; Yin J Aging (Albany NY); 2019 Jul; 11(14):4858-4875. PubMed ID: 31310241 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of long non-coding RNA HOST2 inhibits the proliferation of triple negative breast cancer via regulation of the let-7b/CDK6 axis. Zhang Y; Zhang H; Kang H; Huo W; Zhou Y; Zhang Y Int J Mol Med; 2019 Feb; 43(2):1049-1057. PubMed ID: 30483747 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer. Zuo Y; Li Y; Zhou Z; Ma M; Fu K Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533 [TBL] [Abstract][Full Text] [Related]
12. Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer. Mitobe Y; Ikeda K; Sato W; Kodama Y; Naito M; Gotoh N; Miyata K; Kataoka K; Sasaki H; Horie-Inoue K; Inoue S Cancer Sci; 2020 Jul; 111(7):2440-2450. PubMed ID: 32437068 [TBL] [Abstract][Full Text] [Related]
13. LncRNA TCONS_l2_00002973 correlates with less advanced tumor stage and favorable survival, and also inhibits cancer cells proliferation while enhancing apoptosis in triple-negative breast cancer. Yan J; Wang R; Wu Z J BUON; 2019; 24(2):535-542. PubMed ID: 31128002 [TBL] [Abstract][Full Text] [Related]
14. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448. Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489 [TBL] [Abstract][Full Text] [Related]
15. Up-regulation of long non-coding RNA AWPPH inhibits proliferation and invasion of gastric cancer cells via miR-203a/DKK2 axis. Li L; Kou J; Zhong B Hum Cell; 2019 Oct; 32(4):495-503. PubMed ID: 31489578 [TBL] [Abstract][Full Text] [Related]
16. LncRNA DANCR contributes to tumor progression via targetting miR-216a-5p in breast cancer: lncRNA DANCR contributes to tumor progression. Tao W; Wang C; Zhu B; Zhang G; Pang D Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910842 [TBL] [Abstract][Full Text] [Related]
17. LncRNA NRON down-regulates lncRNA snaR and inhibits cancer cell proliferation in TNBC. Niu L; Fan Q; Yan M; Wang L Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996114 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker. Zhao X; Liu Y; Yu S Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling. Vishnubalaji R; Alajez NM Sci Rep; 2021 Jul; 11(1):15410. PubMed ID: 34326372 [TBL] [Abstract][Full Text] [Related]
20. The long noncoding RNA sONE represses triple-negative breast cancer aggressiveness through inducing the expression of miR-34a, miR-15a, miR-16, and let-7a. Youness RA; Hafez HM; Khallaf E; Assal RA; Abdel Motaal A; Gad MZ J Cell Physiol; 2019 Nov; 234(11):20286-20297. PubMed ID: 30968427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]